29 January 2025
HARGREAVES SERVICES PLC (the “Group”, the “Company” or “Hargreaves”) Interim Results for the six months ended 30 November 2024 Hargreaves Services plc (AIM: HSP),…
28 January 2025
Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris / New York – 28 January 2025 – Euronext (Euronext: ENX), the leading European capital market infrastructure,…
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP GSK plc (LSE/NYSE: GSK) today announced…
HENRY BOOT PLC (‘Henry Boot’ or ‘the group’) TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2024 Henry Boot, a company engaged in land…
Harworth Group plc (“Harworth” or “the Group”) Trading Update Strong operational performance and record land sales driving NDV growth Harworth, a leading regenerator of…
Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more…
Dotdigital Group plc (“Dotdigital”, the ” Company”, or the “Group”) Trading Update & Notice of Half Year Results Positive momentum underpinned by enhanced product offering…
27 January 2025
27 January 2025 Smithson Investment Trust plc (the “Company”) Publication of Investment Manager’s review The Company has today published a letter to shareholders from the…